In July, Pulse Infoframe CEO Dr. Femida Gwadry-Sridhar chaired the 10th Annual Orphan Drugs & Rare Diseases – West Coast Conference in San Francisco and delivered a keynote talk on the role of real-world evidence and natural history studies in targeting better drug development.
In September, Femida participated in the EveryLife Foundation Rare Disease Scientific Workshop in Washington, DC; chaired the 11th Annual Orphan and Drugs and Rare Diseases – East Coast conference in Boston, where she delivered a keynote and led a workshop titled “Opportunity for Real-World Evidence in Improving Patient Outcomes”; presented at the Rare Fair virtual conference, and presented a poster at the ESMO Congress in Spain.
Pulse Infoframe will be at the Society for Participatory Medicine and the Connected Health conferences in Boston and the 9th annual SMi Annual Conference on Orphan Drugs and Rare Diseases in London in October. In November, you will find us at the CDKL5 Annual Forum in Boston and the World Orphan and Rare Disease Europe conference, and in December at BioData (Europe).
Dr. Marcus Butler and Dr. Femida Gwadry-Sridhar presenting their poster, “Opportunity for Real-World Evidence in Improving Patient Outcomes,” in Spain.
This story first appeared in our October 2019 newsletter. Get Pulse Infoframe news delivered to your inbox. Email us to sign up today.
